Cargando…
FDA-Approved Amoxapine Effectively Promotes Macrophage Control of Mycobacteria by Inducing Autophagy
Antibiotic resistance poses a significant hurdle in combating global public health crises, prompting the development of novel therapeutics. Strategies to enhance the intracellular killing of mycobacteria by targeting host defense mechanisms offer numerous beneficial effects, which include reducing c...
Autores principales: | Wang, Jia, Sha, Jian, Strong, Emily, Chopra, Ashok K., Lee, Sunhee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9602717/ https://www.ncbi.nlm.nih.gov/pubmed/36129262 http://dx.doi.org/10.1128/spectrum.02509-22 |
Ejemplares similares
-
Resensitization of methicillin-resistant Staphylococcus aureus by amoxapine, an FDA-approved antidepressant
por: Wilson, Tyler J., et al.
Publicado: (2018) -
Amoxapine-induced tardive dyskinesia
por: Singh, Gurvinder Pal
Publicado: (2009) -
Targeting Autophagy as a Strategy for Developing New Vaccines and Host-Directed Therapeutics Against Mycobacteria
por: Strong, Emily J., et al.
Publicado: (2021) -
Salts of Amoxapine with Improved Solubility for Enhanced
Pharmaceutical Applicability
por: Joshi, Mayank, et al.
Publicado: (2018) -
FDA approved vaccines for monkeypox: Current eminence
por: Chopra, Hitesh, et al.
Publicado: (2022)